Summary
Results from the Randomized Evaluation of Long-Term Anticoagulant Therapy [RE-LY] trial showed that the oral direct thrombin inhibitor dabigatran is a safe and effective alternative to warfarin for the prevention of stroke in patients with atrial fibrillation.
- Cardiology Clinical Trials
- Arrhythmias
- Cerebrovascular Disease
- © 2009 MD Conference Express